BIOA-B.STBIOA-B.STSTO

Revenue (LTM)

$2.0B

+676.8% YoY

Net Income (LTM)

$1.0B

+677.3% YoY

Free Cash Flow

Revenue CAGR (5Y)

+100.1%

Marginsimproving

FCF($0.0B)

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	23	228↑886.3%	616↑169.8%	257↓58.2%	1,999↑676.8%
Gross Profit	-32	154↑582.3%	526↑241.9%	230↓56.2%	1,940↑742.1%
Operating Income	-140	-10↑92.7%	253↑2586.9%	-229↓190.5%	1,368↑698.7%
Net Income	-120	-11↑90.7%	229↑2150.9%	-177↓177.2%	1,022↑677.3%
EBITDA	-126	4↑103.2%	295↑7236.5%	-165↓155.9%	1,381↑936.3%
EPS Diluted	-1.36	-0.13↑90.4%	2.59↑2092.3%	-2.00↓177.2%	11.52↑676.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	848	805↓5.1%	612↓24.1%	513↓16.1%	1,040↑102.8%
Total Current Assets	862	821↓4.8%	1,153↑40.4%	1,011↓12.3%	2,487↑146.1%
Total Assets	898	858↓4.4%	1,186↑38.2%	1,112↓6.3%	2,575↑131.7%
Total Current Liabilities	101	71↓30.0%	125↑76.3%	176↑40.6%	521↑196.5%
Total Liabilities	109	72↓33.9%	140↑93.6%	217↑55.4%	608↑180.6%
Total Equity	789	786↓0.3%	1,047↑33.1%	895↓14.5%	1,967↑119.8%
Total Debt	16	10↓36.8%	5↓50.4%	54↑989.1%	72↑33.5%
Net Debt	-833	-795↑4.5%	-607↑23.7%	-459↑24.4%	-968↓111.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-140	-32↑77.5%	310↑1078.9%	-316↓202.1%	1,431↑552.4%
Capital Expenditure	-4	-13↓190.6%	-7↑41.6%	-27↓257.9%	-1,431↓5272.9%
Free Cash Flow	-145	-44↑69.4%	302↑781.0%	-343↓213.5%	0
Stock-Based Comp	2	3↑76.0%	16↑484.7%	0	0
Net Change in Cash	-152	-43↑71.6%	-194↓350.5%	-99↑49.1%	528↑634.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance